Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Ventricular stimulation" patented technology

Methods, systems and devices for reducing communication burden between leadless pacemakers

PendingUS20250010081A1Heart stimulatorsSensorsBiomedical engineeringPacemaker system
An atrial leadless pacemaker (aLP), of a dual chamber leadless pacemaker system that also includes a ventricular leadless pacemaker (vLP), senses intrinsic atrial events and for each intrinsic atrial event that is sensed determines a respective atrial-to-atrial interval (AA interval) that corresponds to a duration between the intrinsic atrial event and an immediately preceding intrinsic atrial event. Additionally, the aLP, based on the determined AA intervals, selectively transmits and selectively abstains from transmitting atrial event messages to the vLP. When the aLP abstains from transmitting atrial event messages to the vLP, the aLP conserves power thereby increasing its longevity. The aLP can also be configured to operate in a similar manner for paced atrial events, to further conserve power. The vLP utilizes its VV interval timer to determine when to deliver ventricular stimulation, during those times that the aLP abstains from transmitting atrial event messages to the vLP.
Owner:PACESETTER INC

Systems and methods for wireless endocardial stimulation of left ventricular septal wall

To provide favorable systems and methods for wireless endocardial stimulation of the left ventricular septal wall.SOLUTION: The present technology is generally directed to medical implantation of, e.g., stimulation assemblies for stimulating the septal wall of the heart of a human patent, and associated methods. In some embodiments, a stimulation assembly includes a body, circuitry positioned at least partially within the body, an electrode, and an anchor coupled to the body. The anchor can be secured to the septal wall such that the body is positioned within the left ventricle of the heart and such that the electrode engages tissue of the septal wall. The circuitry can be configured to receive acoustic energy and to convert the acoustic energy to electrical energy, and the electrode can deliver the electrical energy to the tissue of the septal wall to stimulate the tissue.SELECTED DRAWING: Figure 2
Owner:EBR SYSTEMS INC

Simulation method and system for optimizing heart turn-back induction based on infarction area distance

The invention discloses a simulation method and system for optimizing heart turn-back induction based on an infarction region distance, and belongs to the field of heart modeling simulation. A personalized high-fidelity ventricle model is constructed based on a CMRLGE image of an arrhythmia patient, each model is divided into regions, pacing points are randomly selected to induce VT, and induction states such as unstable turn-back, stable turn-back and non-persistent turn-back are obtained. Extracting a left ventricular grid model, calibrating a left ventricular myocardial infarction area and a boundary, and measuring a left ventricular stimulation point-infarction area distance for a pace-making point; and carrying out normality test and significance analysis on the distance data of all patients in the induction state, and if significance is met, optimizing the position of the pace-making point, namely summarizing the distance data in the stable turn-back state, and determining the distance range of easily inducing turn-back. The simulation method disclosed by the invention is easy to induce a turn-back similar to a clinical real situation, and can effectively guide a clinician to accurately find an optimal ablation target spot during a VT ablation operation.
Owner:ZHEJIANG UNIV

Implantable medical device for stimulating a human or animal heart featuring a ventricular stimulation upon detection of a premature ventricular contraction

PCT designated stage expiredWO2025108634A1Heart stimulatorsVentricular contractionBiology
The invention relates to an implantable medical device for stimulating a human or animal heart. The implantable medical device comprises at least one electrode (20, 21) that comprises a distal dipole (203) and is designed and arranged to be implanted within the septum (13) of the heart (1) to be stimulated. During operation, the implantable medical device performs the following steps: a) detecting, with the at least one electrode (20, 21), at least one of an intrinsic atrial signal and an intrinsic ventricular signal, or stimulating, with the at least one electrode (20, 21), the atrium (2) of the heart (1) to be stimulated; b) triggering a stimulation of the ventricle (5) of the heart (1) to be stimulated upon i) detecting the intrinsic atrial signal, ii) stimulating the atrium (2), or iii) detecting the intrinsic ventricular signal, wherein triggering upon i) detecting the intrinsic atrial signal or ii) stimulating the atrium (2) is carried out only with a predeterminable temporal delay, and triggering upon iii) detecting the intrinsic ventricular signal is carried out without temporal delay but only if a predeterminable first time period has passed since a preceding ventricular signal, the first time period representing an allowable minimum ventricular interval.
Owner:BIOTRONIK SE & CO KG

Implantable medical device for cardiac resynchronization therapy featuring automatic adaptation of stimulation parameters

The invention relates to an implantable medical device for stimulating a human or animal heart, the device comprising a single electrode (20) comprising a proximal electrode pole (213) designed and arranged to be implanted within an atrium (2) of the heart (1) to be stimulated and a distal electrode pole (203) designed and arranged to be implanted within a septum (13) of the heart (1) to be stimulated. During operation, the implantable medical device performs the following steps: a) detecting (500) an intrinsic atrial contraction of the heart (1) to be stimulated with the proximal electrode pole (213) or stimulating (500) the atrium (2) of the heart (1) to be stimulated with the proximal electrode pole (213); b) detecting (530) an intrinsic ventricular contraction of the heart (1) to be stimulated with the distal electrode pole (203); c) determining (530) an intrinsic atrioventricular conduction time between i) the intrinsic atrial contraction or the stimulation of the atrium and ii) the intrinsic ventricular contraction; d) setting (550) a stimulated atrioventricular conduction time for stimulating a ventricle (3, 5) of the heart (1) to be stimulated with the distal electrode pole (203), the stimulated atrioventricular conduction time being shorter than the intrinsic atrioventricular conduction time.
Owner:BIOTRONIK SE & CO KG